Latest data and clinical guidance
The cardiovascular metabolism (CVM) Learning Zone hosted on Medthority.com features over 70 expert opinion videos covering type 2 diabetes and hypertension.
This WFH guideline provides the first evidence-based recommendations for implementing AAV gene therapy in haemophilia care. It addresses patient selection, safety considerations, standardisation of clinical practice and shared decision-making to support effective integration of gene therapy into routine management.
This ESC guideline updates the classification and management of heart failure, aiming to improve clinical implementation and patient care. It introduces a stage-based framework that emphasises prevention, earlier disease recognition and timely intervention, while incorporating new evidence to refine treatment recommendations and heart failure therapy nomenclature.
The iCARDIO Alliance provides evidence-based recommendations for heart failure management that are intended to support implementation across diverse healthcare systems. The guideline integrates novel therapies, current standards of care and resource-adjusted treatment strategies to improve patient outcomes worldwide.
Developed by the Cystic Fibrosis Foundation, these evidence-informed recommendations address the assessment, management and communication of pain in people living with cystic fibrosis. The guidance promotes a multimodal approach to pain care, with consideration of age, underlying causes of pain, health equity and quality-of-life outcomes.
These EAU guidelines provide evidence‑based recommendations for the diagnosis, treatment, and prevention of urological infections. They cover common and complex infections across urological practice to support effective and safe patient management.
The EAU PCa Guidelines were first published in 2001. Standard procedure for EAU Guidelines includes an annual assessment of newly published literature in the field to guide future updates. This 2025 PCa Guidelines present a limited update of the 2024 publication.
The European Association of Urology (EAU) presents updated guidelines on the evidence-based management of urolithiasis. These recommendations address urinary tract stone treatment, including bladder stones, and consider geographic variations in care delivery.
These EAU guidelines provide evidence‑based recommendations for the diagnosis, staging, treatment, and follow‑up of testicular cancer. They aim to support optimal clinical decision‑making across disease stages and risk groups.